Pakistan Pharmaceutical Manufacturers Association (PPMA) said that prices of essential and life-saving medicines, including insulin, had not been increased, 24NewsHD TV reported on Saturday.
In a statement issued today, PPMA said that supplies of all major drugs remained stable across the country, rejecting concerns over shortages or recent price hikes.
The association said life-saving medicines remained under government price controls and that there had been no increase in the prices of essential drugs in recent months, despite rising production costs, including higher prices of petrol, diesel, and imported raw materials.
“Insulin and all other life-saving medicines remain under government control, and there has been no increase in their prices,” the PPMA said, adding that medicines for all major illnesses were available without interruption nationwide.
The association said supplies of antibiotics, cardiac drugs, blood pressure medication, and diabetes treatment were continuing as normal, while vaccine distribution had also not faced any disruption.
It added that pharmaceutical companies currently held sufficient stocks of both raw materials and finished products to meet demand.
The PPMA said nearly 90% of the medicines used in Pakistan were manufactured locally, helping maintain supply continuity despite cost pressures and external market challenges.
However, the association acknowledged that shortages of some advanced medicines were linked to delays in the issuance of official price notifications.
It said the availability of certain high-end cancer treatments, vaccines and immunoglobulins remained conditional on timely government notification of approved prices, adding that faster issuance of such notifications could further improve access.
The pharmaceutical body also urged media outlets to avoid publishing unverified reports about drug shortages or price increases.
Reporter: Baber Shahzad Turk